Heritage Investment Group Inc. bought a new position in MetLife, Inc. (NYSE:MET – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 2,484 shares of the financial services provider’s stock, valued at approximately $205,000.
Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of MetLife by 3.4% during the first quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider’s stock valued at $4,418,612,000 after purchasing an additional 1,974,268 shares in the last quarter. Swedbank AB bought a new position in shares of MetLife during the first quarter valued at approximately $131,456,000. Acadian Asset Management LLC boosted its stake in shares of MetLife by 7,837.0% during the second quarter. Acadian Asset Management LLC now owns 1,129,353 shares of the financial services provider’s stock valued at $79,250,000 after purchasing an additional 1,115,124 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of MetLife by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock valued at $378,799,000 after purchasing an additional 988,666 shares in the last quarter. Finally, Bessemer Group Inc. boosted its stake in shares of MetLife by 29.7% during the first quarter. Bessemer Group Inc. now owns 2,120,275 shares of the financial services provider’s stock valued at $157,133,000 after purchasing an additional 485,811 shares in the last quarter. 89.81% of the stock is currently owned by institutional investors.
MetLife Stock Performance
MET stock traded up $0.73 during midday trading on Friday, hitting $83.33. 4,393,104 shares of the stock traded hands, compared to its average volume of 3,330,660. The stock’s fifty day simple moving average is $81.60 and its 200-day simple moving average is $75.56. MetLife, Inc. has a 1-year low of $61.61 and a 1-year high of $86.94. The firm has a market cap of $57.70 billion, a P/E ratio of 16.80, a PEG ratio of 0.74 and a beta of 1.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16.
MetLife Dividend Announcement
Wall Street Analysts Forecast Growth
A number of research firms recently commented on MET. Piper Sandler increased their target price on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. TD Cowen began coverage on shares of MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 target price for the company. Wells Fargo & Company increased their target price on shares of MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Jefferies Financial Group increased their target price on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Finally, Citigroup increased their target price on shares of MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a research report on Tuesday, July 23rd. Fourteen analysts have rated the stock with a buy rating, According to data from MarketBeat.com, MetLife presently has a consensus rating of “Buy” and an average target price of $88.46.
Read Our Latest Research Report on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- What Does Downgrade Mean in Investing?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 3 Healthcare Dividend Stocks to Buy
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How to buy stock: A step-by-step guide for beginners
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.